Back to news

Molina Healthcare Gains as Investors Weigh Sector Tailwinds and Near-Term Catalysts

Investivoq PriceTracker

Molina Healthcare (MOH) is up 3.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of improving sentiment toward managed-care stocks and Molina-specific positioning ahead of upcoming results. There does not appear to be a single definitive company announcement today, so part of the move could be because investors are reacting to recent Medicare Advantage quality-rating updates, Molina’s October earnings date, and the start of new contract activity in Illinois.

Details:

  • CMS published 2027 Medicare Advantage and Part D Star Ratings on October 8, a closely watched update for health insurers because star performance can affect future bonuses, rebates, and enrollment competitiveness.
  • Molina has already scheduled its third-quarter 2026 earnings release for October 21, with a conference call on October 22, which may be encouraging positioning ahead of results.
  • In Molina’s latest quarterly filing, the company said its Illinois HealthChoice Medicaid managed care contract was expected to commence on October 1, 2026, giving investors a fresh growth milestone to focus on.
  • Molina’s second-quarter 2026 results beat consensus on adjusted earnings per share, which may still be supporting confidence that margins and execution are stabilizing after a volatile year.

    • Sources:

    Molina Healthcare, CMS, SEC

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MOH Insider Trading Activity

    MOH Insider Trades

    $MOH insiders have traded $MOH stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:

    • JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
    • MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive MOH Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $MOH Hedge Fund Activity

    We have seen 336 institutional investors add shares of $MOH stock to their portfolio, and 250 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • LINGOTTO INVESTMENT MANAGEMENT LLP added 2,511,490 shares (+inf%) to their portfolio in Q2 2026, for an estimated $574,377,763
    • FMR LLC removed 1,333,634 shares (-41.6%) from their portfolio in Q2 2026, for an estimated $305,002,095
    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,154,688 shares (-89.5%) from their portfolio in Q2 2026, for an estimated $264,077,145
    • JANE STREET GROUP, LLC removed 829,536 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $189,714,883
    • AQR CAPITAL MANAGEMENT LLC added 697,208 shares (+24.3%) to their portfolio in Q2 2026, for an estimated $159,451,469
    • MAVERICK CAPITAL LTD removed 645,768 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $147,687,141
    • CAPITAL WORLD INVESTORS removed 636,433 shares (-19.9%) from their portfolio in Q2 2026, for an estimated $145,552,227

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $MOH Price Targets

    Multiple analysts have issued price targets for $MOH recently. We have seen 9 analysts offer price targets for $MOH in the last 6 months, with a median target of $191.0.

    Here are some recent targets:

    • Andrew Mok from Barclays set a target price of $184.0 on 07/09/2026
    • Ben Hendrix from RBC Capital set a target price of $248.0 on 07/09/2026
    • John Stansel from JP Morgan set a target price of $191.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $167.0 on 06/04/2026
    • A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
    • Michael Ha from Baird set a target price of $163.0 on 05/11/2026
    • Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.